CTRI/2020/05/025491已完成2 期
Double blind, placebo controlled, multi-centric,cluster randomized study to evaluate the efficacy of Homeopathic medicines inthe prevention of COVID-19 in Quarantined or Exposed Individuals
ife Force Foundation Trust0 个研究点目标入组 2,233 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 2,233
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Quarantined individuals
- •Covid19 exposure risk groups (For example, police, hospital staff, etc.)
- •The participant is willing and able to give informed consent for participation in the study
- •Agrees not to self-medicate with potential antivirals
排除标准
- •i. Subjects who are detected SARS-CoV-2 positive at baseline ii. Inability to be followed up for the trial period
- •iii. Subjects who are scheduled to receive any other investigational drug during the study.
研究者
相似试验
进行中（未招募）
1 期
Study evaluating the efficacy of bezafibrate for people suffering of primary sclerosing cholangitisAdult patients with primary sclerosing cholangitisEUCTR2019-001015-23-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)104
招募中
2 期
Multi-centered, placebo-controlled, double-blind, randomized clinical trial to assess the effect of oral inosine on the onset of wearing off in patients with early stage Parkinson's diseases diseaseParkinson's diseaseJPRN-UMIN000020527Ehime University Graduate School of Medicine100
已完成
4 期
Multicentric, randomised, double-blind, placebo-controlled 12-months-study in overweight or obese patients to compare two treatment regimes (polyglucosamine L112 vs. placebo)E66.00E66.01DRKS00000358Certmedica International GmbH100
进行中（未招募）
1 期
Clinical study to evaluate eficacy of Pitolisant for children from 6 to 18 years with narcolepsy with/without cataplexyarcolepsyMedDRA version: 20.0Level: LLTClassification code 10028715Term: Narcolepsy with cataplexySystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 22.1Level: LLTClassification code 10048322Term: Narcolepsy aggravatedSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10028713Term: NarcolepsySystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 21.1Level: LLTClassification code 10048323Term: Cataplexy aggravatedSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10007737Term: CataplexySystem Organ Class: 10029205 - Nervous system disordersEUCTR2013-001506-29-ITBIOPROJET PHARMA108
已完成
3 期
Double-blind, randomised, multi-centre, placebo-controlled clinical trial to investigate the efficacy and safety of a combination of comfrey root extract plus methyl nicotinate versus a preparation containing methyl nicotinate alone or placebo in patients with conditions of acute upper or low back paiM54.5M54.6Low back painPain in thoracic spineDRKS00000326Merck Selbstmedikation GmbH379